Publication | Closed Access

A modified thrombin generation assay to evaluate the plasma coagulation potential in the presence of emicizumab, the bispecific antibody to factors IXa/X

ThrombopoiesisThrombosisModified Thrombin GenerationPlasma Coagulation PotentialAutoimmune DiseaseAllergyBispecific AntibodyMedicineImmunologyHematologyHemostasisAntibody ScreeningAutoimmunityFibrinolysisCoagulopathyClinical ChemistryImmunotherapyLaboratory Medicine